rna
knockdown
vivo
carri
signific
potenti
diseas
model
therapi
despit
emerg
approach
perman
knock
target
gene
strategi
target
rna
disrupt
advantag
treatment
acquir
metabol
disord
perman
modif
genom
dna
appropri
rna
viru
infect
diseas
pathogen
dna
avail
mer
infect
recent
famili
rnatarget
crispr
effector
shown
accomplish
robust
downregul
cellular
rna
mammalian
cell
vitro
among
variou
subtyp
casrx
show
potent
rna
knockdown
effici
cell
howev
rnatarget
activ
still
need
verifi
vivo
studi
casrx
system
demonstr
effici
function
knock
gene
relat
metabol
function
includ
pten
lnclstr
mous
hepatocyt
casrxmedi
simultan
knockdown
multipl
gene
also
achiev
sgrna
array
provid
use
strategi
modul
complex
metabol
network
moreov
aav
adenoassoci
viru
mediat
deliveri
casrx
sgrna
mous
liver
success
decreas
serum
result
signific
reduct
serum
cholesterol
level
importantli
casrxmedi
knockdown
authorfund
right
reserv
reus
allow
without
permiss
biorxiv
preprint
revers
could
repeatedli
downregul
provid
effect
strategi
revers
modul
metabol
gene
present
work
suppli
success
proofofconcept
trial
suggest
effici
regulatori
knockdown
target
metabol
gene
design
metabol
modul
liver
target
inhibit
metabol
regulatori
gene
often
use
model
develop
therapi
metabol
diseas
moller
saviano
baumert
past
decad
mani
strategi
metabol
regul
achiev
use
variou
modul
includ
numer
small
molecular
compound
nucleic
acid
therapeut
polypeptidesprotein
target
individu
multipl
defin
molecular
product
enzym
circul
protein
cellsurfac
receptor
cellular
rna
moller
applic
metabol
modul
great
potenti
diseas
model
therapi
howev
develop
novel
approach
specif
flexibl
modul
metabol
gene
vivo
still
challeng
natur
synthes
modul
high
target
specif
theoret
limit
recent
year
increas
number
genet
modif
tool
emerg
repres
one
greatest
breakthrough
crisprca
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
system
offer
sequencespecif
dna
edit
method
correct
mutant
gene
inherit
metabol
diseas
show
remark
benefit
establish
metabol
diseas
anim
model
inherit
tyrosinemia
barrang
doudna
rossidi
et
al
xue
et
al
yao
et
al
howev
perman
modif
dna
usual
optim
strategi
therapi
acquir
metabol
disord
recent
breakthrough
rnaguid
rnatarget
system
class
type
vi
crisprca
effector
report
remark
capabl
rna
edit
without
perman
modif
dna
theoret
rnatarget
system
could
provid
much
safer
approach
gene
silenc
abudayyeh
et
al
cox
et
al
konermann
et
al
pineda
et
al
among
system
casrx
recent
found
advantag
mostli
effici
robust
activ
rnaguid
rna
cleavag
mammalian
cell
vitro
konermann
et
al
yan
et
al
casrx
type
vid
effector
small
size
packag
aav
thu
great
potenti
translat
medicin
konermann
et
al
yan
et
al
zhang
et
al
studi
set
explor
feasibl
use
casrx
system
target
silenc
metabol
gene
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
one
metabol
regulatori
gene
pten
chosen
first
studi
investig
whether
casrx
could
gener
target
metabol
gene
effici
knockdown
sgrna
design
target
code
sequenc
pten
mrna
prepar
fig
casrx
pten
sgrna
introduc
plasmid
transfect
mous
neuroblastoma
cell
fig
hour
cell
transfect
casrx
pten
sgrna
analyz
evalu
level
pten
mrna
expect
design
pten
sgrna
reveal
success
downregul
level
pten
mrna
fig
next
improv
knockdown
effici
test
strategi
combin
differ
pten
sgrna
individu
fig
c
combin
treatment
reduct
pten
mrna
level
success
reach
effici
combin
fig
b
fig
previous
pten
known
metabol
regul
suppress
insulin
signal
inhibit
pathway
cho
et
al
stile
et
al
delet
pten
promot
akt
phosphoryl
stile
et
al
accordingli
effect
also
shown
result
success
knockdown
pten
combin
cell
transfect
casrx
pten
protein
level
significanti
decreas
akt
phosphoryl
level
significantli
elev
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
unintend
widespread
offtarget
silenc
one
major
hurdl
applic
rna
interfer
rnai
jackson
et
al
pecot
et
al
casrx
system
howev
report
significantli
reduc
offtarget
event
compar
rnai
approach
konermann
et
al
set
compar
casrx
system
spacer
sequencematch
shrna
knockdown
pten
via
transient
transfect
cell
consist
previou
studi
ptentarget
shrna
render
widespread
offtarget
transcript
chang
fig
contrast
transfect
spacermatch
casrx
system
induc
significantli
reduc
transcript
chang
fig
importantli
pten
significantli
chang
gene
fig
result
valid
high
specif
casrxmedi
transcript
interfer
next
casrxmedi
knockdown
target
gene
broadli
studi
among
metabol
regulatori
gene
proprotein
convertas
subtilisinkexin
type
crucial
protein
serum
ldl
cholesterol
regul
lambert
et
al
total
candid
sgrna
design
test
goal
target
code
region
fig
expect
sgrna
candid
show
effect
robust
knockdown
mrna
cell
transfect
sgrna
fig
moreov
casrxmedi
target
knockdown
could
also
appli
lnclstr
liverenrich
lncrna
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
togeth
casrx
system
abl
effici
function
knock
metabol
gene
includ
lncrna
gene
could
relat
metabol
function
vitro
cultur
mammalian
cell
success
establish
method
casrxmedi
gene
knockdown
cultur
mammalian
cell
vitro
feasibl
vivo
metabol
gene
target
studi
three
metabol
gene
pten
lnclstr
studi
determin
whether
gene
knockdown
effect
hepatocyt
first
effect
casrxmedi
pten
gene
knockdown
liver
studi
evalu
pten
mrna
level
casrx
deliv
mous
liver
hydrodynam
tailvein
inject
indic
plasmid
fig
hydrodynam
tailvein
inject
simpl
yet
effect
method
use
deliv
nake
dna
hepatocyt
mous
liver
vivo
kim
ahituv
hour
plasmid
inject
individu
hepatocyt
dissoci
liver
perfus
hepatocyt
express
gfp
mcherri
impli
success
vector
deliveri
purifi
cell
sort
though
mathemat
signific
result
suggest
pten
mrna
level
gfpmcherri
hepatocyt
decreas
comparison
gfpmcherryhepatocyt
fig
second
vivo
casrxmedi
gene
knockdown
mous
liver
studi
hydrodynam
inject
casrx
system
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mrna
level
gfpmcherri
hepatocyt
significantli
decreas
gfpmcherryhepatocyt
fig
also
significantli
reduc
protein
level
gfpmcherri
hepatocyt
fig
next
feasibl
casrx
system
knockdown
long
noncod
rna
lncrna
vivo
investig
lnclstr
liverenrich
lncrna
regul
lipid
metabol
inhibit
li
et
al
similar
method
vivo
vector
deliveri
hydrodynam
inject
plasmid
encod
casrx
encod
perform
fig
hepatocyt
receiv
two
plasmid
show
signific
reduct
lnclstr
fig
casrxmedi
lnclstr
knockdown
suffici
result
reduc
express
fig
thu
effici
knockdown
lncrna
success
obtain
hepatocyt
use
casrx
system
effort
explor
feasibl
use
casrx
system
simultan
knockdown
multipl
gene
clone
vector
encod
casrx
gfp
togeth
sgrna
target
pten
lnclstr
fig
hydrodynam
tailvein
inject
plasmid
liver
simultan
decreas
three
target
gene
provid
power
platform
simultan
knockdown
multipl
metabol
gene
fig
evalu
function
modul
metabol
gene
casrx
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
first
employ
piggybac
transposon
system
transfer
casrx
ptentarget
sgrna
hepatocyt
hydrodynam
inject
fig
four
day
inject
gfpexpress
casrx
plasmid
observ
scatter
hepatocyt
reduc
pten
stain
fig
importantli
gfp
hepatocyt
also
neg
low
pten
stain
fig
also
observ
increas
akt
phosphoryl
hepatocyt
receiv
casrx
plasmid
suggest
function
knockdown
pten
cell
fig
character
hepatocyt
receiv
casrx
plasmid
isol
gfp
hepatocyt
fac
sort
gfp
hepatocyt
show
significantli
reduc
express
pten
increas
akt
phosphoryl
fig
h
explor
function
activ
akt
signal
cascad
investig
respons
lipid
glucos
metabolismrel
gene
downstream
akt
result
show
pten
knockdown
significantli
increas
express
fasn
fatti
acid
synthas
sterol
regulatori
elementbind
gfp
hepatocyt
fig
consist
previou
find
stile
et
al
pteninhibit
signal
found
critic
lipogenesi
regul
liver
activ
akt
repress
key
transcript
factor
requir
express
fasn
haeusler
et
al
et
al
therefor
decreas
pten
promot
express
fasn
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
fig
togeth
result
indic
casrx
system
could
use
function
knock
pten
vivo
next
effici
livertarget
gene
deliveri
system
appli
increas
effect
vivo
knockdown
fig
shen
et
al
secret
hepatocyt
great
promis
candid
drug
target
among
regul
serum
cholesterol
steinberg
witztum
accumul
evid
show
inhibit
lower
serum
cholesterol
level
chan
et
al
rossidi
et
al
increas
plasma
ldl
cholesterol
level
one
major
caus
coronari
heart
diseas
chd
cardiovascular
diseas
cvd
well
mani
diseas
larosa
et
al
law
et
al
thu
chose
casrx
system
appli
gene
knockdown
hepatocyt
purpos
reduc
serum
cholesterol
level
deliv
casrx
liver
significantli
reduc
mrna
level
fig
b
serum
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
level
knockdown
mice
reduc
noninject
wildtyp
mice
week
aav
infect
fig
serum
total
cholesterol
level
reduc
normal
level
fig
moreov
liver
function
aavinject
mice
salineinject
noninject
mice
similar
observ
obviou
liver
injuri
mice
fig
f
thu
casrx
system
provid
effici
tool
target
reduc
serum
cholesterol
vivo
investig
whether
casrxmedi
gene
knockdown
revers
remov
casrx
system
deliv
casrx
plasmid
express
gfp
cre
sgrna
liver
rosacaglsltdtomato
mice
hydrodynam
inject
fig
casrx
plasmid
express
lacztarget
sgrna
use
control
hepatocyt
receiv
plasmid
could
trace
express
red
fluoresc
protein
tdtomato
one
day
inject
plasmid
mrna
level
hepatocyt
receiv
casrx
plasmid
tdtomato
decreas
hepatocyt
without
plasmid
gfptdtomato
fig
along
gradual
loss
casrx
plasmid
hepatocyt
mrna
level
gradual
recov
normal
level
day
inject
fig
fig
importantli
secondround
inject
plasmid
achiev
similar
effici
knockdown
compar
firstround
plasmid
inject
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
result
suggest
remark
superior
casrx
system
revers
gene
knockdown
earli
studi
success
obtain
firsthand
inform
experi
realiz
potenti
feasibl
approach
gene
knockdown
rna
interfer
casrx
systemderiv
approach
specif
effici
konermann
et
al
yan
et
al
studi
demonstr
casrx
system
could
effici
target
rna
knockdown
hepatocyt
provid
robust
method
inactiv
gene
polyploid
cell
vivo
anoth
advantag
casrx
small
size
consid
therapeut
potenti
barrang
doudna
konermann
et
al
current
casrx
smallest
class
crispr
effector
avail
mammalian
cell
konermann
et
al
small
size
aa
one
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
casrx
protein
molecul
make
possibl
packag
casrx
aav
togeth
multipl
guid
rna
konermann
et
al
zhang
et
al
fig
highlight
potenti
therapeut
use
rnatarget
crispr
effector
casrx
especi
appeal
correspond
pengyu
huang
hui
yang
c
pten
downstream
signal
protein
akt
analyz
western
blot
cell
transfect
plasmid
encod
casrx
two
sgrna
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
left
volcano
plot
differenti
transcript
level
ptentarget
nontarget
nt
casrx
guid
rna
right
volcano
plot
differenti
transcript
level
ptentarget
nontarget
nt
casrx
guid
rna
